Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Elizabeth Fox,

Elizabeth Fox

faculty photo
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
Division of Oncology
CTRB4016
3501 Civic Center Blvd
Philadelphia, PA 19104
Education:
BS (Laboratory Sciences)
Northeastern University, College of Pharmacy & Allied Health, Boston, MA, 1988.
MD
Pennsylvania State University College of Medicine Hershey, PA, 1993.
MS (Clinical Research)
Duke University College of Medicine Durham, NC, 2006.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient: Nella AA, Lodish MB, Fox E, Balis FM, Quezado MM, Whitcomb PO, Kebebew E, Widemann BC, Stratakis CA. J Clin Endocrinol Metab March 2014.

49. Widemann BC, Dombi E, Gilespie A, Wolters P, Belasco J, Goldman S, Korf B, Solomon J, Martin S, Salzer W, Fox E, Patronas N, Kieran M, Perentesis J, Reddy A, Wright J, Kim A, Steinberg S, Balis FM. Phase II randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas : Phase II randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas Neuro Oncology Feb 2014.

Norris R, Adamson PC, Nguyen VT, Fox E: Preclinical Evaluation of the PARP Inhibitor, Olaparib, in Combination with Cytotoxic Chemotherapy in Pediatric Solid Tumors. Pediatric Blood and Cancer 61(1): 145-50, January 2014.

Widemann BC, Babovic-Vuksanovic D., Dombi E, Wolters PL, Goldman S, Martin S, Goodwin A., Goodspeed, W, Kieran, MW, Cohen B., Blaney SM., King A., Solomon J., Patronas N., Balis, FM., Fox, E, Steinberg SM., Packer RJ. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. : Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Pediatric Blood and Cancer 2014.

DuBois SG, Mosse YP, Fox E, Reid J, Groshen S, Tsao-Wei D, Bagatell R, Maris J, Wagner L, Marachelian A, Matthay K: Phase I Study of the Aurora A Kinase Inhibitor MLN8237 with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma: A Report from the New Approaches to Neuroblastoma Therapy (NANT) Consortium Advances in Neuroblastoma Research 2014.

Fox E, Mosse YP, Meany HM, Gurney JG, Khanna G, Jackson HA, Gordon G, Shusterman S, Park JR, Cohn CL, Adamson PC, London WB, Maris JM, Balis FM.: Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: A report from the Children's Oncology Group (ANBL0621) Pediatric Blood and Cancer Dec 2013.

Fox E, Widemann BC, Chuk MK, Marcus LM, Aikin A, Whitcomb PO, Merino MJ, Lodish M, Dombi E, Steinberg S, Wells SA, Balis FM: Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin Cancer Res 19(15) 4239-48, 2013 19(15): 4239-48, August 2013.

Bagatell R, Norris R, Ingle AM, Ahern CH, Voss S, Fox E, Little A, Weigel B, PA Adamson PA, Blaney SM : Phase 1 Trial of Temsirolimus in Combination with Irinotecan and Temozolomide in Children, Adolescents and Young Adults with Relapsed or Refractory Solid Tumors: A Children’s Oncology Group Study. Pediatric Blood and Cancer 61(5): 833-9, May 2013.

Kim Aerang, Dombi Eva, Tepas Kathleen, Fox Elizabeth, Martin Staci, Wolters Pamela, Balis Frank M, Jayaprakash Nalini, Turkbey Baris, Muradyan Naira, Choyke Peter L, Reddy Alyssa, Korf Bruce, Widemann Brigitte C: Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. Pediatric blood & cancer 60(3): 396-401, March 2013.

Lodish MB, Bornstein E, Sinali N, Fox E, Chuk M, Marcus L, Srivandana A, Whitcomb PO, Akin A, Balis FM, Widemann BC, Stratakis CA. Patterns of Thyroid Hormone Levels in Athyrotic Pediatric Medullary Thyroid Carcinoma Patients on Vandetanib Therapy : Patterns of Thyroid Hormone Levels in Athyrotic Pediatric Medullary Thyroid Carcinoma Patients on Vandetanib Therapy ENDO2013 San Francisco, CA (2013). ENDO2013 San Francisco, CA 2013.

back to top
Last updated: 03/24/2014
The Trustees of the University of Pennsylvania